<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang J</submitter><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>440</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9076672</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(5)</volume><pubmed_abstract>The activation of pancreatic stellate cells (PSCs) is the key mechanism of pancreatic fibrosis, which can lead to β-cell failure. Oxidative stress is an important risk factor for PSC activation. There is no direct evidence proving if administration of glutathione can inhibit fibrosis and β-cell failure. To explore the role of glutathione in pancreatic fibrosis and β-cell failure induced by hyperglycaemia, we established a rat model of pancreatic fibrosis and β-cell failure. The model was founded through long-term oscillating glucose (LOsG) intake and the setup of a sham group and a glutathione intervention group. In vitro, rat PSCs were treated with low glucose, high glucose, or high glucose plus glutathione to explore the mechanism of high glucose-induced PSC activation and the downstream</pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>Glutathione prevents high glucose-induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS/TGFβ/SMAD pathway.</pubmed_title><pmcid>PMC9076672</pmcid><funding_grant_id>82070855</funding_grant_id><pubmed_authors>Zhou Q</pubmed_authors><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Zhou C</pubmed_authors><pubmed_authors>An H</pubmed_authors><pubmed_authors>Bai J</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Li M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Glutathione prevents high glucose-induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS/TGFβ/SMAD pathway.</name><description>The activation of pancreatic stellate cells (PSCs) is the key mechanism of pancreatic fibrosis, which can lead to β-cell failure. Oxidative stress is an important risk factor for PSC activation. There is no direct evidence proving if administration of glutathione can inhibit fibrosis and β-cell failure. To explore the role of glutathione in pancreatic fibrosis and β-cell failure induced by hyperglycaemia, we established a rat model of pancreatic fibrosis and β-cell failure. The model was founded through long-term oscillating glucose (LOsG) intake and the setup of a sham group and a glutathione intervention group. In vitro, rat PSCs were treated with low glucose, high glucose, or high glucose plus glutathione to explore the mechanism of high glucose-induced PSC activation and the downstream</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-26T04:43:14.412Z</modification><creation>2025-02-19T03:27:27.709Z</creation></dates><accession>S-EPMC9076672</accession><cross_references><pubmed>35523788</pubmed><doi>10.1038/s41419-022-04894-7</doi></cross_references></HashMap>